N-acetylglucosaminyltransferase deficiency (Q94050): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Changed label, description and/or aliases in pt-br, en
‎Changed an Item
 
(5 intermediate revisions by the same user not shown)
Property / Canonical URI
 
Property / Canonical URI: https://id.who.int/icd/entity/650208613 / rank
 
Normal rank
Property / CURIE
 
CID11:ID_650208613
Property / CURIE: CID11:ID_650208613 / rank
 
Normal rank
Property / Canary Token
 
dki-india-ID_650208613
Property / Canary Token: dki-india-ID_650208613 / rank
 
Normal rank
Property / Verification Status
 
Concluído
Property / Verification Status: Concluído / rank
 
Normal rank
Property / Knowledge Architect
 
Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank
 
Normal rank
Property / Collection date
 
15 August 2026
Timestamp+2026-08-15T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / Collection date: 15 August 2026 / rank
 
Normal rank

Latest revision as of 09:10, 16 August 2026

The CDG (Congenital Disorders of Glycosylation) syndromes are a group of autosomal recessive disorders affecting glycoprotein synthesis. CDG syndrome type IIa is characterised by severe psychomotor delay, postnatal growth retardation, facial dysmorphology and bleeding tendency. It has been described in four children. The syndrome is associated with mutations in the MGAT2 gene (localised to the q21 region of chromosome 14) leading to a deficiency in the Golgi apparatus enzyme, N-acetylglucosaminyl transferase (GlcNAc-T II).
Language Label Description Also known as
default for all languages
ID_650208613
    English
    N-acetylglucosaminyltransferase deficiency
    The CDG (Congenital Disorders of Glycosylation) syndromes are a group of autosomal recessive disorders affecting glycoprotein synthesis. CDG syndrome type IIa is characterised by severe psychomotor delay, postnatal growth retardation, facial dysmorphology and bleeding tendency. It has been described in four children. The syndrome is associated with mutations in the MGAT2 gene (localised to the q21 region of chromosome 14) leading to a deficiency in the Golgi apparatus enzyme, N-acetylglucosaminyl transferase (GlcNAc-T II).

      Statements

      CID11:ID_650208613
      0 references
      dki-india-ID_650208613
      0 references
      Concluído
      0 references
      15 August 2026
      0 references